Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening

Histopathology

Volumn 53, Issue 6, 2008, Pages 650-657

  El Sayed, M E ^a,b   Rakha, E A ^a   Reed, J ^a   Lee, A H S ^a   Evans, A J ^a   Ellis, I O ^a,c  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b MENOUFIA UNIVERSITY   (Egypt)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

B3; Needle core biopsy; Positive predictive value; Screen detected breast lesions

Indexed keywords

ARTICLE; BREAST CANCER; BREAST LESION; DIAGNOSTIC ACCURACY; HISTOLOGY; HUMAN; MAMMOGRAPHY; NEEDLE BIOPSY; PRIORITY JOURNAL; TUMOR CLASSIFICATION;

AGED; BIOPSY, NEEDLE; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; UNCERTAINTY;

PHYLLODES;

EID: 57049153945     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03158.x     Document Type: Article

References (36)

1. Lamb J, Anderson TJ, Dixon MJ, Levack PA. Role of fine needle aspiration cytology in breast cancer screening. J. Clin. Pathol. 1987 40 705 709.
2. Pinder SE, Elston CW, Ellis IO. The role of pre-operative diagnosis in breast cancer. Histopathology 1996 28 563 566.
3. Shannon J, Douglas-Jones AG, Dallimore NS. Conversion to core biopsy in preoperative diagnosis of breast lesions: is it justified by results? J. Clin. Pathol. 2001 54 762 765.
4. Litherland JC, Evans AJ, Wilson AR et al. The impact of core-biopsy on pre-operative diagnosis rate of screen detected breast cancers. Clin. Radiol. 1996 51 562 565.
5. Britton PD, Flower CD, Freeman AH et al. Changing to core biopsy in an NHS breast screening unit. Clin. Radiol. 1997 52 764 767.
6. Rakha EA, Ellis IO. An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens. J. Clin. Pathol. 2007 60 1300 1306.
7. NHSBSP Breast Screening Programme. Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening. Sheffield : NHSBSP Pub No. 50, 2001.
8. Houssami N, Ciatto S, Bilous M, Vezzosi V, Bianchi S. Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3). Br. J. Cancer 2007 96 1253 1257.
9. Dillon MF, McDermott EW, Hill AD et al. Predictive value of breast lesions of "uncertain malignant potential" and "suspicious for malignancy" determined by needle core biopsy. Ann. Surg. Oncol. 2007 14 704 711.
10. Lee AH, Denley HE, Pinder SE et al. Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3). Histopathology 2003 42 331 336.
11. NHS Breast Screening Programme. Guidelines for pathology reporting in breast cancer screening, 3rd edn and Royal College of Pathologists'Minimum dataset for breast cancer histopathology, 2nd edn. Sheffield : NHSBSP Pub. No. 58, 2005.
12. Andreu FJ, Saez A, Sentis M et al. Breast core biopsy reporting categories - an internal validation in a series of 3054 consecutive lesions. Breast 2007 16 94 101.
13. Ibrahim AE, Bateman AC, Theaker JM et al. The role and histological classification of needle core biopsy in comparison with fine needle aspiration cytology in the preoperative assessment of impalpable breast lesions. J. Clin. Pathol. 2001 54 121 125.
14. Harvey JM, Sterrett GF, Frost FA. Atypical ductal hyperplasia and atypia of uncertain significance in core biopsies from mammographically detected lesions: correlation with excision diagnosis. Pathology 2002 34 410 416.
15. Lieske B, Ravichandran D, Alvi A, Lawrence DA, Wright DJ. Screen-detected breast lesions with an indeterminate (B3) core needle biopsy should be excised. Eur. J. Surg. Oncol. 2008 34 1293 1298.
16. Shah VI, Flowers CI, Douglas-Jones AG, Dallimore NS, Rashid M. Immunohistochemistry increases the accuracy of diagnosis of benign papillary lesions in breast core needle biopsy specimens. Histopathology 2006 48 683 691.
17. Jackman RJ, Nowels KW, Rodriguez-Soto J et al. Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up. Radiology 1999 210 799 805.
18. Crisi GM, Mandavilli S, Cronin E, Ricci A Jr. Invasive mammary carcinoma after immediate and short-term follow-up for lobular neoplasia on core biopsy. Am. J. Surg. Pathol. 2003 27 325 333.
19. Elsheikh TM, Silverman JF. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am. J. Surg. Pathol. 2005 29 534 543.
20. Middleton LP, Grant S, Stephens T et al. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Mod. Pathol. 2003 16 120 129.
21. Carder PJ, Garvican J, Haigh I, Liston JC. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast. Histopathology 2005 46 320 327.
22. Rosen EL, Bentley RC, Baker JA, Soo MS. Imaging-guided core needle biopsy of papillary lesions of the breast. Am. J. Roentgenol. 2002 179 1185 1192.
23. Sydnor MK, Wilson JD, Hijaz TA, Massey HD, Shaw de Paredes ES. Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy. Radiology 2007 242 58 62.
24. Liberman L, Tornos C, Huzjan R et al. Is surgical excision warranted after benign, concordant diagnosis of papilloma at percutaneous breast biopsy? Am. J. Roentgenol. 2006 186 1328 1334.
25. Jacobs TW, Connolly JL, Schnitt SJ. Nonmalignant lesions in breast core needle biopsies: to excise or not to excise? Am. J. Surg. Pathol. 2002 26 1095 1110.
26. Mercado CL, Hamele-Bena D, Oken SM, Singer CI, Cangiarella J. Papillary lesions of the breast at percutaneous core-needle biopsy. Radiology 2006 238 801 808.
27. Cawson JN, Malara F, Kavanagh A et al. Fourteen-gauge needle core biopsy of mammographically evident radial scars: is excision necessary? Cancer 2003 97 345 351.
28. Farshid G, Rush G. Assessment of 142 stellate lesions with imaging features suggestive of radial scar discovered during population-based screening for breast cancer. Am. J. Surg. Pathol. 2004 28 1626 1631.
29. Patterson JA, Scott M, Anderson N, Kirk SJ. Radial scar, complex sclerosing lesion and risk of breast cancer. Analysis of 175 cases in Northern Ireland. Eur. J. Surg. Oncol. 2004 30 1065 1068.
30. Doyle EM, Banville N, Quinn CM et al. Radial scars/complex sclerosing lesions and malignancy in a screening programme: incidence and histological features revisited. Histopathology 2007 50 607 614.
31. Jacobs TW, Chen YY, Guinee DG Jr. et al. Fibroepithelial lesions with cellular stroma on breast core needle biopsy: are there predictors of outcome on surgical excision? Am. J. Clin. Pathol. 2005 124 342 354.
32. Lee AH, Hodi Z, Ellis IO, Elston CW. Histological features useful in the distinction of phyllodes tumour and fibroadenoma on needle core biopsy of the breast. Histopathology 2007 51 336 344.
33. Carder PJ, Liston JC. Will the spectrum of lesions prompting a "B3" breast core biopsy increase the benign biopsy rate? J. Clin. Pathol. 2003 56 133 138.
34. Carder PJ, Murphy CE, Liston JC. Surgical excision is warranted following a core biopsy diagnosis of mucocoele-like lesion of the breast. Histopathology 2004 45 148 154.
35. Renshaw AA. Can mucinous lesions of the breast be reliably diagnosed by core needle biopsy? Am. J. Clin. Pathol. 2002 118 82 84.
36. Wang J, Simsir A, Mercado C, Cangiarella J. Can core biopsy reliably diagnose mucinous lesions of the breast? Am. J. Clin. Pathol. 2007 127 124 127.